X
Sosei shares tank after safety issue with Alzheimer’s drug
https://pharmaphorum.com/news/sosei-shares-tank-after-safety-issue-with-alzheimers-drug/
Alzheimer’s
Biogen and Eisai Alzheimer’s drug excites doctors, but not investors
Investors spooked after string of failures
vTv’s azeliragon is latest Alzheimer’s drug failure
vTv to stop all studies after STEADFAST trial failure
Digital in action against Alzheimer’s disease
Digital technologies are both helping to transform the public’s perception of dementia, and enabling everyone to help scientific research into the disease by playing a smartphone game that tests navigation skills.
